Physician profile
Geoffrey L Risley
NPI 1578565735
$96,197.62
in general payments reported to CMS, 2019-2025
25 companies · $33K in 2025
The $33K reported for 2025 was more than what 96% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,028 · 2020: $2,514 · 2021: $6,082 · 2022: $2,185 · 2023: $14K · 2024: $33K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $71K · Food and Beverage: $8,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $71,166.67 |
| Food and Beverage | $8,221.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $73,412.58 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $7,477.31 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis |
| Endologix LLC | $5,624.61 | 2019-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Medtronic, INC. | $3,302.99 | 2021-2025 | Venaseal, Closurefast |
| Penumbra, INC. | $1,681.58 | 2021-2025 | Indigo System, Penumbra System, Ruby Coil |
| Bolton Medical INC | $807.58 | 2020-2024 | Treo Abdominal Stent-Graft System |
| Silk Road Medical, INC. | $779.44 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $606.40 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $462.29 | 2019-2025 | Limflow System, Clottriever Bold Catheter, Flowtriever |
| Medtronic Vascular, INC. | $398.01 | 2019-2020 | |
| Veryan Medical Incorporated | $330.08 | 2020-2023 | Biomimics 3d Vascular Stent System |
| Bard Peripheral Vascular, INC. | $272.33 | 2020 | |
| Boston Scientific Corporation | $176.45 | 2025 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System, General - Vascular Intervention |
| Venclose INC. | $154.22 | 2020 | |
| Abbott Laboratories | $152.63 | 2023-2025 | Jeti, Xact |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $146.45 | 2019-2020 | |
| Lemaitre Vascular, INC. | $101.20 | 2019-2022 | |
| Osiris Therapeutics INC. | $61.14 | 2019 | |
| Davol INC. | $57.13 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $55.77 | 2021-2022 | |
| Organogenesis INC. | $47.28 | 2023 | Puraply |
| Philips North America LLC | $34.79 | 2019 | |
| Cook Medical LLC | $26.80 | 2019-2023 | Zenith Spiral-Z |
| Ethicon US, LLC | $16.87 | 2024 | Ethicon, Evarrest |
| Cardiovascular Systems INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Risley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.